Table 4.
Depressive Symptoms (Burnam Score ≥0.06) | Use of Antidepressant Medication | |||||||
No. of Cases | Total No. | ORa for Supplementation vs. Placebo | 95% CI | No. of Users | Total No. | ORa for Supplementation vs. Placebo | 95% CI | |
Total vitamin D intake, IU/dayb | ||||||||
<100 | 46 | 418 | 0.61 | 0.30, 1.22 | 350 | 4,965 | 0.89 | 0.68, 1.16 |
100–<200 | 49 | 487 | 2.84 | 1.38, 5.83 | 550 | 7,570 | 1.20 | 0.96, 1.49 |
200–<400 | 34 | 390 | 1.80 | 0.82, 3.97 | 509 | 6,382 | 0.96 | 0.76, 1.21 |
400–<600 | 53 | 520 | 0.91 | 0.49, 1.70 | 683 | 8,018 | 0.92 | 0.76, 1.13 |
≥600 | 37 | 379 | 0.99 | 0.47, 2.05 | 574 | 6,468 | 1.09 | 0.87, 1.36 |
Pinteraction | 0.03 | 0.32 | ||||||
Dietary vitamin D intake, IU/day | ||||||||
<100 | 70 | 687 | 0.88 | 0.51, 1.52 | 668 | 8,989 | 0.91 | 0.75, 1.11 |
100–<200 | 76 | 876 | 1.46 | 0.87, 2.44 | 1,127 | 14,039 | 1.10 | 0.94, 1.28 |
200–<400 | 59 | 529 | 1.39 | 0.76, 2.53 | 725 | 8,782 | 0.96 | 0.79, 1.17 |
≥400 | 14 | 102 | 0.99 | 0.29, 3.35 | 146 | 1,593 | 1.13 | 0.73, 1.76 |
Pinteraction | 0.55 | 0.45 | ||||||
Supplemental vitamin D intake, IU/day | ||||||||
None | 127 | 1,201 | 1.38 | 0.91, 2.07 | 1,296 | 17,367 | 1.02 | 0.89, 1.18 |
<400 | 20 | 207 | 1.15 | 0.43, 3.11 | 272 | 3,383 | 1.04 | 0.76, 1.43 |
400–<800 | 68 | 733 | 1.04 | 0.61, 1.78 | 1,038 | 11,882 | 0.99 | 0.84, 1.17 |
≥800 | 4 | 53 | 0.22 | 0.02, 2.63 | 60 | 771 | 0.86 | 0.44, 1.69 |
Pinteraction | 0.48 | 0.96 | ||||||
Total calcium intake, mg/dayb | ||||||||
<400 | 29 | 221 | 0.50 | 0.20, 1.24 | 146 | 2,358 | 0.87 | 0.58, 1.31 |
400–<800 | 65 | 655 | 1.76 | 0.98, 3.17 | 661 | 8,831 | 1.00 | 0.82, 1.22 |
800–<1,000 | 24 | 293 | 1.81 | 0.73, 4.48 | 403 | 4,682 | 1.24 | 0.96, 1.61 |
1,000–<1,200 | 19 | 244 | 1.16 | 0.43, 3.19 | 301 | 4,154 | 0.98 | 0.73, 1.32 |
≥1,200 | 82 | 781 | 1.05 | 0.63, 1.73 | 1,155 | 13,378 | 0.97 | 0.83, 1.14 |
Pinteraction | 0.18 | 0.52 | ||||||
Dietary calcium intake, mg/day | ||||||||
<400 | 39 | 380 | 0.61 | 0.29, 1.29 | 318 | 4,429 | 0.94 | 0.71, 1.25 |
400–<800 | 96 | 932 | 1.28 | 0.80, 2.04 | 1,098 | 14,298 | 0.98 | 0.84, 1.14 |
800–<1,000 | 24 | 328 | 2.57 | 1.01, 6.55 | 450 | 5,448 | 1.15 | 0.90, 1.47 |
1,000–<1,200 | 24 | 231 | 1.03 | 0.41, 2.60 | 270 | 3,526 | 1.26 | 0.92, 1.73 |
≥1,200 | 36 | 323 | 1.27 | 0.59, 2.73 | 530 | 5,702 | 0.90 | 0.71, 1.13 |
Pinteraction | 0.21 | 0.37 | ||||||
Supplemental calcium intake, mg/day | ||||||||
None | 114 | 1,024 | 1.28 | 0.83, 1.99 | 1,070 | 14,334 | 1.00 | 0.85, 1.17 |
<400 | 47 | 528 | 1.47 | 0.77, 2.82 | 697 | 7,987 | 1.13 | 0.92, 1.38 |
400–<800 | 29 | 382 | 0.97 | 0.43, 2.19 | 516 | 6,342 | 0.93 | 0.74, 1.17 |
≥800 | 29 | 260 | 0.80 | 0.34, 1.88 | 383 | 4,740 | 0.96 | 0.74, 1.26 |
Pinteraction | 0.66 | 0.63 |
Abbreviations: AD, antidepressant; CI, confidence interval; OR, odds ratio.
Multivariable models adjusted for age, race/ethnicity, WHI Hormone Trial intervention, and WHI Dietary Modification Trial intervention. The analysis of risk of depressive symptoms above the threshold level (Burnam score ≥0.06) included adjustment for this variable at year 1. The analysis of risk of antidepressant use included adjustment for antidepressant use at year 1.
Total nutrient intake = dietary nutrient intake (assessed at year 0) + supplemental nutrient intake (assessed at year 1).